Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
P 2 (1)

Trial Status

Active Not Recruiting1
Not Yet Recruiting1
Recruiting1

Clinical Trials (3)

Showing 3 of 3 trials
NCT06683534Phase 2Not Yet Recruiting

Palmitic Acid and Human Microvascular Function

NCT06043310Active Not Recruiting

Estrogen and Microvascular Function

NCT06758648Recruiting

Characterizing the Retinal Microvasculature in Patients with Fabry Disease: a Prospective Observational Study

Showing all 3 trials

Research Network

Activity Timeline